Latest news with #AIHA
Business Wire
2 days ago
- Business
- Business Wire
SHOEBOX Wins Inaugural AIHA Connect Spirit of Innovation Award for PureTest Product
FALLS CHURCH, Va.--(BUSINESS WIRE)-- AIHA is proud to announce that SHOEBOX, a division of WS Audiology, has been named the winner of the inaugural Spirit of Innovation Award—the SPINNY—at AIHA Connect 2025, held in Kansas City, MO, May 19-21, 2025. SHOEBOX won this year's top honor for its groundbreaking SHEOBOX PureTest solution. Designed to revolutionize how environmental and occupational health professionals test and monitor hearing in the workplace, SHOEBOX PureTest integrates portability, a user-friendly interface, and clinical-grade accuracy into a single, accessible device. 'SHOEBOX exemplifies the kind of forward-thinking ingenuity we had in mind when launching the Spirit of Innovation Award,' said AIHA CEO Lawrence D. Sloan, FASAE, CAE. 'SHOEBOX PureTest offers a unique blend of mobility, efficiency, and effectiveness that enhances workplace safety and expands access to reliable hearing testing—particularly for field and remote operations.' Selected by votes of in-person and virtual conference attendees, the SPINNY Award celebrates the vital role of innovation in shaping the future of occupational and environmental health and safety. SHOEBOX PureTest stood out for its approach to hearing health monitoring, promising to set a new standard across industries. SHOEBOX developed the first ever iPad-based audiometer and released PureTest specifically for occupational hearing conservation, eliminating the need for sound booths during OSHA- mandated annual testing. With best-in-class ambient noise monitoring, SHOEBOX PureTest ensures the testing environment meets ANSI and OSHA standards. It's an ideal solution for companies managing their own hearing conservation programs or service providers managing programs for others, enabling OSHA-compliant workplace hearing testing anywhere. 'We're honored to receive the first-ever Spirit of Innovation Award,' said Rob Walesa, VP of Diagnostic Solutions at WS Audiology. 'This recognition affirms our commitment to transforming hearing testing through innovative technology. It's a testament to the passion and dedication of our incredible team.' AIHA congratulates SHOEBOX and thanks all the exhibitors who continue to drive progress and creativity in the field. The 2026 SPINNYs will return to AIHA Connect 2026, June 1-3 in New Orleans, LA, continuing to highlight the products and solutions that define the next generation of worker health and safety tools. About SHOEBOX For the last decade, SHOEBOX has been leading the evolution of hearing testing solutions for occupational hearing conservation. For more information on SHOEBOX PureTest, visit About AIHA Connect AIHA Connect is the 'must-attend' event for OEHS professionals at all levels. The annual conference focuses on the important trends, needs, research, technologies, training, and connections that make OEHS professionals more efficient in their pursuit of protecting workerand community health worldwide. About AIHA AIHA is the association for scientists and professionals committed to ensuring occupational and environmental health and safety in the workplace and community. Founded in 1939, we support our members with our expertise, networks, education programs, and other products and services that help them maintain the highest professional standards. AIHA serves those employed across the public and private sectors, as well as to the communities in which they work. For more information, visit
Yahoo
13-06-2025
- Health
- Yahoo
Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine
CHENGDU, China, June 12, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced that Prof. Jun Shi's research team from the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (Institute of Hematology, Chinese Academy of Medical Sciences) has recently published a research report titled "BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy" in the New England Journal of Medicine (NEJM), which has reported for the first time globally the research data on a BCMA x CD3 bispecific antibody treatment for patients with refractory autoimmune hemolytic anemia (AIHA). The study results showed that two patients experienced rapid disease improvement after the administration of CM336, achieving partial remission on days 13 and 19, respectively. Hemoglobin levels returned to normal on days 17 and 21, respectively, while reticulocyte counts, lactate dehydrogenase, and indirect bilirubin levels significantly decreased. Before receiving treatment with CM336, both patients had undergone multiple treatment regimens, including glucocorticoids, splenectomy, anti-CD20 antibodies, BTK inhibitors, and CD19 CAR-T cell therapies, but their disease eventually recurred or progressed to refractory status. The latest assessment results after 6 months post-starting CM336 showed that both patients remained in sustained remission without immunosuppressive therapies or transfusions. No cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), or infection events occurred during the entire treatment and follow-up period. The overall study showed that CM336 had demonstrated positive efficacy signals in treating patients with relapsed/refractory AIHA who had previously received multiple therapies, with rapid disease control and sustained remission lasting over half a year, while also exhibiting good safety profile, potentially making it an innovative treatment option for development in this disease. About CM336CM336 is a BCMA x CD3 bispecific antibody that can simultaneously target and identify and specifically bind both BCMA on the surface of target cells and the CD3 receptors on the surface of T cells to recruit immune T cells to the vicinity of the target cells, thereby inducing T-cell dependent cellular cytotoxicity (TDCC) to eliminate the target cells. As of the date of this announcement, the Phase II clinical study of CM336 for the treatment of primary light-chain amyloidosis has been approved by the Center for Drug Evaluation of the National Medical Products Administration and will commence clinical trials shortly. About Keymed BiosciencesKeymed Biosciences Inc. (HKEX: 02162) is a biotech company focused on the urgent unmet clinical needs, and committed to providing high-quality, affordable, innovative therapies for patients in China and overseas. Keymed was founded by medical and scientific experts who have strong experience in the transformation of scientific and technological achievements to commercialization at home and abroad. View original content: SOURCE Keymed Biosciences
Yahoo
13-06-2025
- Health
- Yahoo
Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine
CHENGDU, China, June 12, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced that Prof. Jun Shi's research team from the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (Institute of Hematology, Chinese Academy of Medical Sciences) has recently published a research report titled "BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy" in the New England Journal of Medicine (NEJM), which has reported for the first time globally the research data on a BCMA x CD3 bispecific antibody treatment for patients with refractory autoimmune hemolytic anemia (AIHA). The study results showed that two patients experienced rapid disease improvement after the administration of CM336, achieving partial remission on days 13 and 19, respectively. Hemoglobin levels returned to normal on days 17 and 21, respectively, while reticulocyte counts, lactate dehydrogenase, and indirect bilirubin levels significantly decreased. Before receiving treatment with CM336, both patients had undergone multiple treatment regimens, including glucocorticoids, splenectomy, anti-CD20 antibodies, BTK inhibitors, and CD19 CAR-T cell therapies, but their disease eventually recurred or progressed to refractory status. The latest assessment results after 6 months post-starting CM336 showed that both patients remained in sustained remission without immunosuppressive therapies or transfusions. No cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), or infection events occurred during the entire treatment and follow-up period. The overall study showed that CM336 had demonstrated positive efficacy signals in treating patients with relapsed/refractory AIHA who had previously received multiple therapies, with rapid disease control and sustained remission lasting over half a year, while also exhibiting good safety profile, potentially making it an innovative treatment option for development in this disease. About CM336CM336 is a BCMA x CD3 bispecific antibody that can simultaneously target and identify and specifically bind both BCMA on the surface of target cells and the CD3 receptors on the surface of T cells to recruit immune T cells to the vicinity of the target cells, thereby inducing T-cell dependent cellular cytotoxicity (TDCC) to eliminate the target cells. As of the date of this announcement, the Phase II clinical study of CM336 for the treatment of primary light-chain amyloidosis has been approved by the Center for Drug Evaluation of the National Medical Products Administration and will commence clinical trials shortly. About Keymed BiosciencesKeymed Biosciences Inc. (HKEX: 02162) is a biotech company focused on the urgent unmet clinical needs, and committed to providing high-quality, affordable, innovative therapies for patients in China and overseas. Keymed was founded by medical and scientific experts who have strong experience in the transformation of scientific and technological achievements to commercialization at home and abroad. View original content: SOURCE Keymed Biosciences Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
05-06-2025
- Health
- Business Wire
AIHA Announces New 2025-2026 Board Members, Prepares for Inaugural Strategic Meeting in New Orleans, LA
FALLS CHURCH, Va.--(BUSINESS WIRE)--AIHA, the association for occupational and environmental health and safety (OEHS) professionals, inducted its new Board of Directors for the 2025-2026 term during its annual business meeting held during the AIHA Connect 2025 conference in Kansas City, MO. The AIHA Board will commence its first Strategic Planning meeting in July in New Orleans, LA, site of AIHA Connect 2026. The 2025-2026 Board of Directors includes officers: President: Bradley S. King, PhD, MPH, CIH President-Elect: Nancy M. McClellan, MPH, CIH, CHMM Vice President: Cheryl Marcham, PhD, CIH, CSP, CHMM, FAIHA Past President: Nicole M.H. Greeson, MS, CIH Secretary: Justine Parker, CIH, CSP, CPH, CHMM Treasurer: Lucinette Alvarado Rivera, CIH Treasurer-Elect: Eric R. White, MPH, CIH, CSP AIHA members serving as directors-at-large include: Isabel Bacarella, MPH, CIH, CSP Vanessa A. Brady, MS, CIH, CSP Matthew M. Dahm, PhD John R. Moore III, CIH, CSP Bradley Rodgers, MS, MBA, CIH, CSP Amy Snow, CIH 'Each member of AIHA's Board of Directors contributes their own unique perspectives and experiences,' said Lawrence Sloan, CEO of AIHA. 'Their knowledge, expertise, dedication, and passion support our mission of promoting and protecting worker health and will contribute significantly to our efforts as we continue to navigate the evolving landscape of occupational health and safety.' Sloan expressed his appreciation for the invaluable contributions made to AIHA by the outgoing Board members: Dina M. Siegel, CIH, CSP, CBSP, FAIHA, former past president; Pamela A. Kostle, CIH, FAIHA, former secretary; and Bryan Seal, PhD, CIH, CSP, CHMM, REHS; former director-at-large. 'Our Board members volunteer significant time and energy during their tenures, and for that we are grateful,' said Sloan. 'Their contributions to AIHA will have lasting effects on our organization and the health and safety of workers and communities around the world.' Details of Newly Elected 2025-2026 Board Members: Cheryl (Cheri) Marcham, PhD, CIH, CSP, CHMM, FAIHA, was elected Vice President. Marcham has previously served on the board as a director-at-large. She has volunteered with several AIHA groups including the Indoor Environmental Quality Committee, Academic Accreditation Panel, Conference Program Committee, Real-Time Detection Systems Committee, and more. She has authored or contributed to several AIHA publications, including serving most recently as Project Team Leader for the Aerosolized Infectious Agents Guidance Document and as Project Team member of the Hierarchy of Controls White Paper, which received the 2024 AIHA President's Award. Marcham is Associate Professor and Program Chair at Embry-Riddle Aeronautical University. Isabel Bacarella, MPH, CIH, CSP, was elected director-at-large. Bacarella has been a member of AIHA since 2010 and previously served as Chair of the Women in Industrial Hygiene Committee, President of the Gulf Coast Local Section, and member of the AIHA Career and Employment Services Group. In 2016, she received the AIHA Outstanding Volunteer Member Award. Bacarella currently works as Manager of Gas Transmission & Midstream (GRM) Safety Operations at Enbridge in Houston, TX. Amy Snow, CIH, was elected director-at-large. Snow has served as Chair of the Healthcare Working Group, Lead of the Hazardous Drug Subcommittee (publishing the AIHA Hazardous Drug Surface Contamination Guidance Document), and Secretary of the Carolinas Local Section. Snow has also served on the Occupational and Environmental Epidemiology Volunteer Group. She currently works for Trinity - SafeBridge Consultants as a Managing Industrial Hygienist. Justine Parker, CIH, CSP, CPH, CHMM and Eric R. White, MPH, CIH, CSP moved from director-at-large roles on the Board to the officer positions of secretary and treasurer respectively. AIHA appreciates their continued support. About AIHA AIHA is the association for scientists and professionals committed to preserving and ensuring occupational and environmental health and safety (OEHS) in the workplace and community. Founded in 1939, AIHA supports worker health and safety through our expertise, networks, comprehensive education programs, and other products and services that help companies maintain the highest professional and competency standards. AIHA serves as a resource for those employed across the public and private sectors and the communities in which they work. For more information visit
Hindustan Times
15-05-2025
- Health
- Hindustan Times
Great discounts on orthopaedic mattresses: Up to 60% off for added comfort and spine health
If you've been waking up with a sore back or struggling to get quality sleep, now's the time to upgrade. There's a massive sale on orthopaedic mattresses, with discounts up to 60 %. These mattresses are designed to support your spine, ease pressure points and offer the right balance of firmness and comfort. Ideal for anyone dealing with back pain or simply wanting a better night's sleep, the options on offer cater to every budget. From memory foam styles to hybrid builds, the best orthopaedic mattresses are now easily accessible. Don't miss the chance to grab the best orthopaedic mattress for your space and finally sort out that lingering backache with a proper mattress for back pain. Results of a systematic review in the U.S. show that a medium-firm mattress promotes comfort, sleep quality and rachis alignment. (National Library Of Medicine. U.S.) Looking for a mattress that gives proper support without compromising on comfort? This Wakefit ShapeSense orthopaedic mattress ticks all the right boxes. Designed with high-density foam and TruDensity technology, it ensures zero sagging and steady back support over time. Ideal for back pain, this medium-firm mattress comes with a breathable cover and advanced memory foam layering. Wakefit ShapeSense Orthopedic Classic Memory Foam Mattress 8-Inch King Size 78x72x8 Inches Space Grey This Sleepyhead mattress blends comfort with clever design, thanks to its BodyIQ memory foam that adjusts to your body shape and sleeping style. With zero partner disturbance, a breathable cover and a balanced medium-firm feel, it's a great choice for those dealing with back pain. Plus, the 10-year warranty and trial period make it risk-free. Sleepyhead Original - 3 Layered BodyIQ Orthopedic Memory Foam Mattress | Zero Partner Disturbance | Medium Firm | 10- Years Warranty | 6-Inch Bed Mattress | 78x60x6 inches (Queen Size Mattress) This Livpure Smart orthopaedic mattress brings tech into your sleep routine with 5D SleepTech zones and ComfortScience foam. Designed to offer firm back support with curved layers for better spine alignment, it helps manage back pain while keeping things breathable and sweat-free. The high GSM washable cover adds a practical edge to the comfort it offers. Livpure Smart Ortho CURVX Memory and Curved Orthopaedic Mattress | 5D SleepTech Crafted Zones | ComfortScience US Tech Foam | High GSM Neon Washable Fabric |King Bed (78x72x6) inch, 10 Year Warranty The Sleep Company's SmartGRID Ortho Mattress brings science into your sleep with its patented Japanese grid tech and AIHA certification. The grid adjusts to your body while keeping airflow in check, making it perfect for back pain relief. It's medium firm, breathable, and designed to support a proper sleeping posture with lasting comfort through the night. The Sleep Company SmartGRID Ortho Mattress | Japanese Patented Technology | AIHA Certified | Medium Firm Orthopedic Mattress for Back Pain Relief | 10 Years Warranty | Queen Size Bed 78x60x5 SleepyCat's Original Ortho Mattress combines breathable comfort with supportive memory foam layers to help ease pressure points and maintain back alignment. Its AirGen™ Memory Foam works against trapped heat, keeping things cooler through the night. With a SoftTouch bamboo cover and medium firm feel, this mattress is ideal for consistent comfort and reduced partner disturbance. SleepyCat Original Ortho Mattress with AirGen™ Memory Foam | Medium Firm Feel for Balanced Comfort | 6 Inch |SoftTouch Bamboo Zipper Cover | 10 Years Warranty (Queen Size,72x60x6 Inch) The Centuary Spine Support Mattress is all about firm comfort for serious back support. Built with high-density coir, ortho foam and rebonded foam, it offers extra firm support and breathability. Its organic cotton fabric cover adds a soft finish while the antimicrobial shield keeps things hygienic. A solid pick for anyone dealing with back pain or posture issues. Centuary Mattresses Spine Support 6 inch Extra Firm Orthopedic Coir Mattress (Queen, 78X60X6) Sleepwell's Ortho Mattress blends memory foam with high-density Resitec foam to offer medium firm support for restful nights. Its breathable fabric cover keeps the mattress fresh, while anti-allergic Neem Fresher Technology adds an organic layer of protection. Designed for balanced spine comfort, this mattress comes with a 10-year warranty for lasting peace of mind. Sleepwell Ortho Mattress | High Density Resitec (HR) Foam | Medium Firm | Memory Foam | Breathable Fabric | Queen Size Mattress | 78X60X6 | 10 Yrs Warranty Flo's Aloe vera-infused mattress offers medium-firm support designed to relieve back pain and promote deep sleep. With PainRelease™ Technology, it targets pressure points and boosts circulation. The cotton blend cover and 3D Air-Flo™ Technology keep you cool and comfortable all night. Perfect for those needing extra spine support and a peaceful rest. Flo Ortho™ Aloe Vera Infused Orthopedic Mattress with PainRelease™ Technology | Medium Firm Feel | 8 inch Mattress in Queen Size (78x60x8 Inches) | 10 Year Warranty More picks for you with Amazon deals Best mattresses for a peaceful and comfortable sleep; Here are our top 8 picks for you Sleep better, live healthier: Orthopaedic comfort up to 70% off on Amazon Mattress matters: Find your dreamy match made in heaven; Nap like a champ! Orthopaedic mattresses are specially designed to provide targeted support to the spine, joints, and muscles. They help maintain proper alignment and reduce pressure points, making them ideal for people with back pain or posture issues. Look for a mattress with medium to firm support that contours to your body shape. Memory foam or high-resilience foam mattresses often work well. Also, consider thickness and any special features like pressure relief or cooling fabrics. Most orthopaedic mattresses last between 7 to 10 years, depending on usage and quality. High-quality materials like memory foam and high-density foams tend to last longer. Yes, they can also relieve pressure on joints, improve posture, reduce tossing and turning, and aid in better sleep quality for conditions like arthritis and sciatica. The author of this article holds a Masters Degree in Interior Design and has spent over a decade in research, teaching, and designing homes from scratch. Disclaimer: At Hindustan Times, we help you stay up-to-date with the latest trends and products. Hindustan Times has an affiliate partnership, so we may get a part of the revenue when you make a purchase. We shall not be liable for any claim under applicable laws, including but not limited to the Consumer Protection Act, 2019, concerning the products. The products listed in this article are in no particular order of priority.
